Publication

ERLOTINIB DERIVATIVES & USES THEREOF

Abstract

The present invention relates to compounds useful in the treatment of cancers, in particular cancers overexpressing the epidermal growth factor receptor (EGFR) such as non-small cell lung or breast cancers.

About this result
This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.